- GILD +2.14%
Search results
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine.
- 65.96Add to watchlist+1.38 (+2.14%)At close:4:00 PM EDTFri. May 10, 202465.70 -0.26 (-0.39%)After hrs:7:53 PM EDTFri. May 10, 2024Nasdaq Real Time Price (USD) · Market closed
- Open64.72High66.20Low64.67
- Mkt Cap82.18BP/E (TTM)183.22Div & Yield3.08 & 4.67%
- Prev. Close64.5852 Wk. Low64.3352 Wk. High87.87
What analysts are sayingTop storiesGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowYahoo Finance · 12 hours ago- GILD +2.14%
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT InsightYahoo Finance · 2 days ago- GILD +2.14%
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call TranscriptYahoo Finance · 1 week agoRelated stocks
Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers.
2 days ago · Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.
Apr 25, 2024 · Learn about the investigational medicines in Gilead's pipeline with the potential to help advance care in COVID-19, HIV, viral hepatitis, cancer and inflammation.
Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Investor Relations. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in.
Per-Share Earnings, Actuals and Estimates. View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ.